Outlook therapeutics, inc. (OTLK)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Jun'15Mar'15
Collaboration revenues

-

-

5,853

583

641

1,067

771

771

771

771

2,902

303

303

303

494

494

994

994

1,294

494

Operating expenses:
Research and development

4,383

5,847

7,404

4,393

5,935

6,071

7,149

5,795

5,156

402

2,307

4,157

4,116

13,227

3,873

12,017

4,138

12,733

9,681

10,154

General and administrative

1,957

2,336

2,782

1,834

1,849

2,903

6,036

2,195

2,446

3,549

3,505

3,481

4,024

4,870

6,574

10,504

-189

4,674

2,659

4,342

Impairment of property and equipment

423

-

-

-

561

2,349

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

6,763

8,184

18,545

6,228

8,346

11,324

13,185

7,991

7,602

3,951

5,812

7,639

8,141

18,098

10,447

22,522

3,948

17,408

12,340

14,496

Loss from operations

-6,763

-8,184

-12,691

-5,644

-7,705

-10,257

-12,413

-7,219

-6,831

-3,179

-2,910

-7,336

-7,837

-17,795

-9,952

-22,027

-2,953

-16,413

-11,045

-14,001

Interest expense, net

696

597

210

1,081

1,053

1,120

1,105

1,147

920

717

2,147

1,745

1,243

489

615

299

537

398

554

705

Loss on extinguishment of debt

0

-8,060

-

-423

-183

-

0

0

0

-1,252

-

-

-

-

-

-

-

-

-

-

Change in fair value of redemption feature

-1,759

-37

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-0

-201

-172

-1,931

1,301

-1,636

-821

64

-211

-78

817

-3,750

-1,035

810

-

0

-

-

-

-

Loss before income taxes

-

-

-

-5,218

-

-

-12,697

-8,431

-7,539

-5,071

-5,875

-5,331

-8,045

-19,094

-10,567

-22,326

-3,491

-16,812

-11,600

-14,707

Income tax benefit

-

-

-

-777

-

-

-497

0

0

-3,150

497

0

0

4

0

0

50

52

120

-726

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,720

-

Less: Net loss attributable to noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-380

-

Net loss

-5,700

-16,602

-10,096

-4,440

-10,244

-9,741

-12,199

-8,431

-7,539

-1,920

-6,373

-5,331

-8,045

-19,098

-10,567

-22,327

-3,542

-16,864

-11,340

-13,981

Beneficial conversion feature upon issuance of Series A-1 convertible preferred stock

-

-

-

-

61

-

286

0

381

15,355

-

-

-

-

-

-

-

-

-

-

Series A-1 convertible preferred stock dividends and related settlement

0

166

162

158

154

150

163

652

636

450

-

-

-

-

-

-

-

-

-

-

Deemed dividend upon modification of warrants

1,431

1,708

-

-

829

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend upon amendment of the terms of the Series A-1 convertible preferred stock

10,328

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of redeemable preferred stock and noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

493

1,030

939

1,091

1,034

Deemed dividends upon the repurchase of Series A redeemable preferred stock and redeemable noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

67

Deemed dividend upon issuance of warrants to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,373

-

-

-

-

Net loss attributable to common stockholders

-17,459

-18,477

-10,258

-4,599

-11,289

-9,892

-12,649

-9,084

-8,558

-17,726

-7,550

-5,331

-8,045

-19,098

-10,567

-30,194

-4,572

-17,803

-12,431

-15,083

Per share information:
Net loss per share of common stock, basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-0.22

-0.34

-

-

-1.60

-0.32

-

-

-

Net loss per share of common stock, diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-0.22

-0.38

-

-

-1.60

-0.32

-

-

-

Weighted average shares outstanding, basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

24,442

23,723

-

-

18,816

14,155

-

-

-

Weighted average shares outstanding, diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

24,442

23,801

-

-

18,816

14,155

-

-

-

Net loss per share of common stock, basic and diluted (in dollars per share)

-0.36

-0.62

0.20

-0.20

-0.98

-1.00

-4.27

-2.10

-2.66

-0.71

-

-

-

-0.82

-

-

-

-1.36

-1.30

-1.61

Weighted average shares outstanding, basic and diluted (in shares)

47,895

29,901

28,387

23,007

11,529

9,843

-12,808

4,317

3,216

25,003

-

-

-

23,196

-

-

-

13,061

9,588

9,377